Novozymes A/S Stock Forecast, Price & News

-2.10 (-2.58 %)
(As of 08/3/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume350 shs
Average Volume1,020 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive NVZMF News and Ratings via Email

Sign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter.

Novozymes A/S logo

About Novozymes A/S

Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.75 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Novozymes A/S (OTCMKTS:NVZMF) Frequently Asked Questions

What stocks does MarketBeat like better than Novozymes A/S?

Wall Street analysts have given Novozymes A/S a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Novozymes A/S wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Novozymes A/S's earnings last quarter?

Novozymes A/S (OTCMKTS:NVZMF) issued its earnings results on Wednesday, April, 20th. The biotechnology company reported $0.37 EPS for the quarter, missing analysts' consensus estimates of $2.43 by $2.06.
View Novozymes A/S's earnings history

How has Novozymes A/S's stock price been impacted by COVID-19?

Novozymes A/S's stock was trading at $45.90 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NVZMF stock has increased by 72.7% and is now trading at $79.25.
View which stocks have been most impacted by COVID-19

Who are Novozymes A/S's key executives?

Novozymes A/S's management team includes the following people:
  • Ester Baiget, President & Chief Executive Officer
  • Graziela Chaluppe dos Santos Malucelli, Chief Operating Officer & Executive VP
  • Lars Green, Chief Financial Officer & Executive Vice President
  • Claus Crone Fuglsang, Chief Scientific Officer & Executive VP
  • Anders Lund, EVP & Head-Consumer Biosolutions

Who are some of Novozymes A/S's key competitors?

What is Novozymes A/S's stock symbol?

Novozymes A/S trades on the OTCMKTS under the ticker symbol "NVZMF."

How do I buy shares of Novozymes A/S?

Shares of NVZMF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Novozymes A/S's stock price today?

One share of NVZMF stock can currently be purchased for approximately $79.25.

How many employees does Novozymes A/S have?

Novozymes A/S employs 6,274 workers across the globe.

What is Novozymes A/S's official website?

The official website for Novozymes A/S is www.novozymes.com.

Where are Novozymes A/S's headquarters?

Novozymes A/S is headquartered at Krogshoejvej 36, BAGSVAERD, 2880, Denmark.

How can I contact Novozymes A/S?

Novozymes A/S's mailing address is Krogshoejvej 36, BAGSVAERD, 2880, Denmark. The biotechnology company can be reached via phone at (454) 446-0000.

This page was last updated on 8/3/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.